Correspondence to Dr John H Stone, Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA 02114, USA; jhstone{at}mgh.harvard.edu IgG4-related disease (IgG4-RD) can cause ...
Correspondence to Professor Alicja Wolk, Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Box 210, Stockholm 171 77, Sweden; Alicja.Wolk{at}ki.se ...
Objective RANKL is mainly expressed by synovial fibroblasts and T cells within the joints of rheumatoid arthritis patients. The relative importance of RANKL expression by these cell types for the ...
1 Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands 2 Julius Center for Health Sciences and Primary Care, University Medical Center ...
Objectives To examine the safety and efficacy of rontalizumab, a humanised IgG1 anti-interferon α (anti-IFN-α) monoclonal antibody, in patients with moderate-to-severe systemic lupus erythematosus ...
‘Poly-refractory’ disease affects 2.7% of patients with rheumatoid arthritis (RA) who have failed different groups of biologic disease-modifying antirheumatic drugs (b-DMARDS) and targeted synthetic ...
F8: Back to the future: how to mix the old and new treatments for SLE, Sjögren's and APS ...
SpA: Innovative techniques in spondyloarthritis research – Is there light at the end of the tunnel for our patients?
Correspondence to Dr Ennio Giulio Favalli, Division of Clinical Rheumatology, Gaetano Pini-CTO, Milano 20122, Lombardia, Italy; ennio.favalli{at}gmail.com The global health emergency generated by the ...
Background: Individuals with rheumatoid arthritis (RA) have an increased risk of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), compared with non-RA ...
1 Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands 2 Department of Rheumatology, Erasmus Medical Center, Rotterdam, The Netherlands Correspondence to A H M van der ...
Objectives Dermatomyositis (DM) has been consistently linked to the type I interferon (IFN-I) pathway. However, the precise pathogenesis remains incompletely elucidated. We aimed to explore potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results